Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

EVO stock hub

Evotec SE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EVOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EVO

In the news

Latest news · EVO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E130.4

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-11.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-7.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EVO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

EUR

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001412558
Company name	Evotec SE
Country	Germany
Country code	US
Cusip	30050E105
Employees	4,467
Employees Change	-273%
Employees Change Percent	-5.76
Enterprise value	$1B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2021-11-04
Isin	US30050E1055
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$3.07
Price currency	USD
Rev Per Employee	207,218.79x
Sector	Healthcare
Sic	2834
Symbol	EVO
Website	https://www.evotec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.22%
EV/EBITDA	102.28x
EV/Sales	1.13x
FCF yield	-8.89%
Forward P/E	130.41x
P/B ratio	1.13x
P/S ratio	1.17x
PE Ratio10 Y	191.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.38%
EBITDA Margin	1.11%
Gross margin	14.49%
Gross Profit	$134.1M
Gross Profit Growth	-0.57%
Gross Profit Growth Q	70.21%
Gross Profit Growth3 Y	-13.1%
Gross Profit Growth5 Y	-1.9%
Net Income	$-121.5M
Net Income Growth Years	1%
Pretax Margin	-11.01%
Profit Margin	-13.13%
Profit Per Employee	$-27,209
ROA	-2.28
Roa5y	-0.74
ROCE	-4.91
ROE	-11.72
Roe5y	-6.22
ROIC	-7.21
Roic5y	-2.38

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-26.39%
Cagr3y	-31.19%
EPS Growth Years	1
FCF Growth Q	-17.09%
OCF Growth Q	-14.27%
Revenue Growth	-1.08x
Revenue Growth Q	14.49x
Revenue Growth Years	0x
Revenue Growth3 Y	1.61x
Revenue Growth5 Y	9.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.43
Assets	$2B
Cash	$559.3M
Current Assets	$899.7M
Current Liabilities	$434.1M
Debt	$525.6M
Debt EBITDA	$15.75
Debt Equity	$0.55
Equity	$955.4M
Liabilities	$1.1B
Long Term Assets	$1.1B
Long Term Liabilities	$622.9M
Net Cash	$33.7M
Net Cash By Market Cap	$3.11
Net Debt EBITDA	$-3.28
Net Debt Equity	$-0.04
Tangible Book Value	$598.5M
Tangible Book Value Per Share	$3.37
WACC	7.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.07
Inventory Turnover	22.31
Net Working Capital	$26M
Quick ratio	1.85
Working Capital	$463.6M
Working Capital Turnover	$2.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-26.38%
200-day SMA	3.37
3Y total return	-67.43%
50-day SMA	2.84
50-day SMA vs 200-day SMA	50under200
All Time High	25.29
All Time High Change	-87.86%
All Time High Date	2021-12-15
All Time Low	2.31
All Time Low Change	33.02%
All Time Low Date	2026-03-13
ATR	0.14
Beta	1.24
Ch YTD	-0.32
High	3.09
High52	4.8
High52 Date	2025-05-23
High52ch	-36.04%
Low	3.03
Low52	2.31
Low52 Date	2026-03-13
Low52ch	33.02%
Ma50ch	7.98%
Premarket Change Percent	1.64
Premarket Price	$3.1
Premarket Volume	1,272
Price vs 200-day SMA	-8.96%
RSI	52.22
RSI Monthly	37.85
RSI Weekly	47.22
Sharpe ratio	-0.31x
Sortino ratio	-0.34
Total Return	-0.16%
Tr YTD	-0.32
Tr1m	18.99%
Tr1w	-0.65%
Tr3m	-13.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Count Top	1
Analyst Price Target Top	$7
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.08
Earnings Revenue Estimate	197,190,000x
Earnings Revenue Estimate Growth	-5.3x
Operating Income	$-77.5M
Operating Income Growth Q	185.5
Operating margin	-8.38
Price target	$7
Price Target Change	$128
Price Target Change Top	$128

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	133,553,222%
Float Percent	75.14%
Net Borrowing	-34,692,592.4
Shares Institutions	35.55%
Shares Out	177,749,400
Shares Qo Q	-0.09%
Shares Yo Y	0.16%
Short Ratio	3.76
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-100.8M
Average Volume	114,174.55x
Bv Per Share	5.37
CAPEX	$-85.2M
Ch1m	18.99
Ch1w	-0.65
Ch1y	-26.38
Ch3m	-13.03
Ch3y	-67.43
Ch6m	-0.32
Change	0.66%
Change From Open	-0.32
Close	3.05
Days Gap	0.98
Depreciation Amortization	88,177,300.4
Dollar Volume	139,896.8
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-77.5M
EBITDA	$10.3M
EPS	$-0.68
F Score	5
FCF	$-96.4M
FCF EV Yield	-9.18x
FCF Per Share	$-0.54
Financing CF	-44,182,224
Fiscal Year End	December
Founded	1,993
Goodwill	321,199,534.9
Income Tax	$19.7M
Investing CF	201,468,827
Ipr	-88.26
Iprfo	-85.31
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2021-10-20
Last Split Type	Forward
Last10k Filing Date	2026-04-08
Ma150	3.26
Ma150ch	-5.91%
Ma20	3.13
Ma20ch	-1.89%
Net CF	131,654,338
Next Earnings Date	2026-08-12
Open	3.08
Optionable	No
Position In Range	66.67
Ppne	654,069,404.1
Pre Close	3.05
Price Date	2026-05-08
Price EBITDA	$106
Ptbv Ratio	1.81
Relative Volume	0.4x
Revenue	925,646,355x
SBC By Revenue	0.48x
Share Based Comp	4,435,834
Tax By Revenue	2.12x
Tr6m	-0.32%
Volume	45,569
Z Score	0.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EVO pay a dividend?

Capital-return profile for this ticker.

Performance

EVO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EVO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.5%

Float: +75.1% of shares outstanding

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EVO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.2

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

1.24

More volatile than the market

Sharpe ratio

-0.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EVO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EVO stock rating?

Evotec SE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EVO analysis?

The full report lives at /stocks/EVO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EVO?

The latest report frames EVO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EVO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.